Table 4 Age, ESR, and CRP levels in patients groups
From: JAK2 mutation may predict response and guide first line treatment in rheumatoid arthritis
|  | Patients | Mean ± SD | T | P |
|---|---|---|---|---|
ESR mm/h | Non-mutant JAK2 (40) | 46.2 ± 20.2 | 0.8 | 0.4 |
Mutant JAK2 (45) | 49.4 ± 15.2 | |||
CRP mg/L | Non-mutant JAK2 (40) | 37.7 ± 32.2 | 1.4 | 0.1 |
Mutant JAK2 (45) | 29.2 ± 22.7 | |||
Age years | Non-mutant JAK2 (40) | 50.4 ± 6.9 | 2.1 | 0.03 |
Mutant JAK2 (45) | 47.1 ± 7.2 |